Search The Medical Knowledge Base

Drug Details

URISPAS

• Drug Class Description
  Antispasmodics.
• Generic Name
  Flavoxate
• Presentation
  Film-coated tablet. White, film-coated tablets embossed with 'F 200'
• Description
  Each Urispas tablet contains flavoxate hydrochloride 200 mg.
• Indications
  

  Urispas is indicated for the symptomatic relief of dysuria, urgency, nocturia, vesical supra-pubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethro-cystitis and urethrotrigonitis.

  In addition, the preparation is indicated for the relief of vesico-urethral spasms due to catheterisation, cystoscopy or indwelling catheters; prior to cystoscopy or catheterisation; sequelae of surgical intervention of the lower urinary tract.

• Adult Dosage
  

  For oral administration.

  Adults (including the elderly):

  The recommended adult dosage is one tablet three times a day for as long as required.

  Children:

  Urispas tablets are not recommended for children under 12 years of age.

• Child Dosage
  

  Urispas tablets are not recommended for children under 12 years of age.

• Contra Indications
  

  The following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastro-intestinal haemorrhage and obstructive uropathies of the lower urinary tract.

  Hypersensitivity to flavoxate hydrochloride or to any of the excipients of Urispas 200.

• Special Precautions
  

  Urispas should be used with caution in patients with suspected glaucoma, especially closed angle cases and in patients with serious, uncontrolled, obstructive disorders of the lower urinary tract.

  Where evidence of urinary infection is present, appropriate anti-infective therapy should be instituted concomitantly.

  Patients with rare hereditary problems of galactose intolerance, the Lapp lactose deficiency or glucose-galactose malabsorption should not take this medicine.

• Adverse Drug Reactions
  

  In clinical trials comparing Urispas with other antispasmodic agents, the incidence of side-effects was low. The following adverse reactions have been observed:

  Blood and lymphatic disorders: Eosinophilia, leukopenia.

  Immune system disorders: Hypersensitivity reactions

  Nervous system disorders: Drowsiness, dizziness, headache, mental confusion (especially in the elderly), nervousness, vertigo.

  Eye disorders: Blurred vision, disturbances in eye accommodation, increased ocular tension.

  Cardiac disorders: Palpitations, tachycardia.

  Gastrointestinal disorders: Diarrhoea, dry mouth, dyspepsia, dysphagia, nausea, vomiting.

  Skin and subcutaneous tissue disorders: Angioedema, urticaria, erythema, rash, pruritis

  Renal and urinary disorders: Dysuria.

  General disorders: Fatigue, hyperpyrexia.